SkyAI (SKYA) Stock Overview

Engages in building an Agentic finance for the global south. More details

SKYA fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	4/6
Dividends	0/6

Risk Analysis

Shareholders have been substantially diluted in the past year

Has less than 1 year of cash runway

Earnings have declined by 91.2% per year over past 5 years

Does not have a meaningful market cap ($59M)

+ 1 more risk

SKYA Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW443,467 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.

Grow your followingReal investors. The kind who actually invest, not scroll past.

Unlock free accessFree premium subscription for consistent and quality authors.

Learn more Create Narrative

443,467 investors already sharing narratives

View all narratives

SkyAI, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for SkyAI
Historical stock prices
Current Share Price	US$1.42
52 Week High	US$9.35
52 Week Low	US$0.91
Beta	2.07
1 Month Change	44.90%
3 Month Change	10.08%
1 Year Change	-84.03%
3 Year Change	-99.90%
5 Year Change	n/a
Change since IPO	-99.90%

Recent updates

Seeking Alpha • Oct 05

Sharps Technology: From Medical Devices To Solana Treasury

Summary Sharps Technology pivoted into a crypto treasury model with a significant Solana allocation, now holding roughly the same SOL amount as peers DFDV and Upexi, both around 2 million SOL. Sharps’ entry into SOL occurred around the $200 price level, below its $293 all-time high, positioning it well for upside if SOL rallies. Sharps’ core safety syringe business continues to face low revenue and inventory buildup, with Q2 revenue at $223k. Q2 net income of $5.5 million was mainly driven by a non-cash fair value gain on warrants remeasured under ASC 815. Read the full article on Seeking Alpha

Shareholder Returns

	SKYA	US Medical Equipment	US Market
7D	2.9%	-5.5%	-0.9%
1Y	-84.0%	-18.1%	13.9%

Return vs Industry: SKYA underperformed the US Medical Equipment industry which returned -18.1% over the past year.

Return vs Market: SKYA underperformed the US Market which returned 13.9% over the past year.

Price Volatility

Is SKYA's price volatile compared to industry and market?
SKYA volatility
SKYA Average Weekly Movement	15.0%
Medical Equipment Industry Average Movement	8.2%
Market Average Movement	6.9%
10% most volatile stocks in US Market	15.3%
10% least volatile stocks in US Market	2.9%

Stable Share Price: SKYA's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: SKYA's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

Founded	Employees	CEO	Website
2017	55	Paul Danner	www.theskyai.co

SkyAI, Inc. engages in building an Agentic finance for the global south. It combines stablecoin rails with AI to deliver financial access, education, and actionable intelligence to the underbanked users in Asia, Latin America, and Africa. The company was formerly known as Sharps Technology, Inc. and changed its name to SkyAI, Inc. in May 2026.

SkyAI, Inc. Fundamentals Summary

How do SkyAI's earnings and revenue compare to its market cap?
SKYA fundamental statistics
Market cap	US$59.32m
Earnings (TTM)	-US$387.63m
Revenue (TTM)	US$5.72m

10.7x

P/S Ratio

-0.2x

P/E Ratio

Is SKYA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SKYA income statement (TTM)
Revenue	US$5.72m
Cost of Revenue	US$955.63k
Gross Profit	US$4.76m
Other Expenses	US$392.39m
Earnings	-US$387.63m

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

n/a

Earnings per share (EPS)	-9.02
Gross Margin	83.29%
Net Profit Margin	-6,778.47%
Debt/Equity Ratio	0%

How did SKYA perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/09/14 21:35
End of Day Share Price	2026/09/14 00:00
Earnings	2026/06/30
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

SkyAI, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
David Bouchey	Aegis Capital Corporation

SkyAI (SKYA) Stock Overview

Risk Analysis

Join community and earn perks

SkyAI, Inc. Competitors

Medinotec

Xtant Medical Holdings

InspireMD

TELA Bio

Price History & Performance

Recent News & Updates

Forward Industries Urges Shareholders of SkyAI to Vote No at the 2026 Annual Meeting

SkyAI, Inc., Annual General Meeting, Sep 18, 2026

Forward Industries, Inc. (NasdaqCM:FWDI) cancelled the acquisition of SkyAI, Inc. (NasdaqCM:SKYA).

Forward Industries, Inc. (NasdaqCM:FWDI) signed a non-binding letter of intent to acquire SkyAI, Inc. (NasdaqCM:SKYA) for $66.5 million.

Sharps Technology Inc. Appoints Arthur Levine as Interim Chief Financial Officer, Effective February 17, 2026

Sharps Technology and Coinbase Expand Relationship with Launch of Institutional-Grade Solana Validator

Recent updates

Forward Industries Urges Shareholders of SkyAI to Vote No at the 2026 Annual Meeting

SkyAI, Inc., Annual General Meeting, Sep 18, 2026

Forward Industries, Inc. (NasdaqCM:FWDI) cancelled the acquisition of SkyAI, Inc. (NasdaqCM:SKYA).

Forward Industries, Inc. (NasdaqCM:FWDI) signed a non-binding letter of intent to acquire SkyAI, Inc. (NasdaqCM:SKYA) for $66.5 million.

Sharps Technology Inc. Appoints Arthur Levine as Interim Chief Financial Officer, Effective February 17, 2026

Sharps Technology and Coinbase Expand Relationship with Launch of Institutional-Grade Solana Validator

Sharps Technology: From Medical Devices To Solana Treasury

Sharps Technology, Inc. (NasdaqCM:STSS) announces an Equity Buyback for $100 million worth of its shares.

Sharps Technology, Inc. has filed a Follow-on Equity Offering in the amount of $236.605575 million.

Sharps Technology, Inc. announced that it has received $400 million in funding from a group of investors

Sharps Technology, Inc., Annual General Meeting, Aug 19, 2025

Nasdaq Notifies Sharps Technology Regarding Non-Compliance with the $2,500,000 Stockholders’ Equity Requirement

Sharps Technology Receives Non-Compliance letter from Nasdaq Regarding Minimum Bid Price Requirement

Sharps Technology, Inc. has completed a Composite Units Offering in the amount of $20 million.

Sharps Technology, Inc., Annual General Meeting, Dec 19, 2024

Sharps Technology Announces Continued Listing on Nasdaq Pending Results of an Upcoming Special Shareholders’ Meeting

New major risk - Market cap size

Sharps Technology, Inc. Receive Non-Compliance Letter Regarding Nasdaq Listing Rule 5550(a)(2)

Sharps Technology, Inc. announced a financing transaction

New major risk - Shareholder dilution

New major risk - Share price stability

Sharps Technology, Inc. has filed a Follow-on Equity Offering in the amount of $14.1 million.

New minor risk - Share price stability

Listing Qualifications Department of the Nasdaq Stock Market LLC Determines Sharps Technology, Inc. Is Eligible for an Additional 180 Calendar Day Period, or Until July 8, 2024, to Regain Compliance

New major risk - Financial position

Sharps Technology, Inc., Annual General Meeting, Dec 19, 2023

New major risk - Shareholder dilution

Sharps Technology, Inc. announced that it expects to receive $5.6 million in funding

Sharps Technology Receives a Notice from the Staff of the Listing Qualifications Department of the Nasdaq Stock Market

Sharps Technology Appoints Ben Scheu as Senior Director of Sales

New major risk - Market cap size

Sharps Technology, Inc. announced that it has received $3.8 million in funding

Sharps Technology, Inc. announced that it expects to receive $3.8 million in funding

Sharps Technology, Inc. Ships First Containers of Safety Syringes to Nephron Pharmaceuticals for Commercialization

Sharps Technology Inc. to Introduces New Specialized Prefillable Syringe Systems in 2023

High number of new and inexperienced directors

Sharps Technology, Inc. (NasdaqCM:STSS) completed the acquisition of Safegard Medical (Hungary) Kft. from Numan Holding Ltd.

High number of new and inexperienced directors

Independent Non-Executive Director recently bought US$140k worth of stock

High number of new and inexperienced directors

Brenda Baird Simpson and Jason Monroe Elects to Sharps Technology, Inc.'s Board of Directors

Sharps Technology, Inc. has completed an IPO in the amount of $15.9375 million.

Shareholder Returns

Price Volatility

About the Company

SkyAI, Inc. Fundamentals Summary

Earnings & Revenue

Company Analysis and Financial Data Status

Data Sources

Analysis Model and Snowflake

Industry and Sector Metrics

Analyst Sources